Latin America - Understanding Regulatory Compliance Requirements Across Life Science Industry PART I

This course specifically focuses on the overall regulatory compliance requirements and procedures for Pharmaceuticals, Medical Devices, Biologics and Combination Products in Latin America. The primary countries covered will include: Argentina, Brazil, Chile, Costa Rica, Dominican Republic, Mexico, Panama, Peru and Venezuela. The course will cover topics relating to pre-clinical and clinical requirements, as well as, addressing the structure of the regulatory agencies in Latin America. Content will include descriptions of the methods by which regulators in the corresponding agencies process filings and registrations and what is expected in the authorization and dossier maintenance of licensed products.

The current regulatory climate in Latin America is discussed in detail and several examples will be provided to illustrate effective compliance procedures and techniques. Common issues that have caused difficulties for Life Sciences firms in the region are outlined. Course content will explain how Latin America interacts with and utilizes ICH standards and how they relate with other national regulatory agencies. Additionally, participants will learn how personnel can best address the conflicts which arise and the best course for resolution.

Areas Covered in the seminar:

• Glossary of Terms.
• Defining the Opportunity.
• Country Facts: Argentina, Brazil, Mexico.
• Latin America's Regulatory Structure for the Life Science Product Industries.
• Mercosur - Southern Common Market.
• Beginning Your Company Involvement in Latin America: Examples of Country Requirements.
• Registration / Required Country Licenses.
• Common Fees.
• Overview of the Rules Governing Medicinal Products & Medical Devices.
  • Select Examples of:Clinical Trials, GCP, GMP, Specials, Marketing Authorizations, Product Classifications, Scientific Advice, Generics Pricing, Patents, Labeling, SPC, Variations, Manufacturing Licenses, Renewals, Pharmacovigilance, Orphan Drugs.
• Comparing & Contrasting Latin America with U.S. FDA.
• Getting Engaged with the Regulatory Process.
• Summary.
• Contact Points / Follow-Up.

Who will benefit:

• Regulatory personnel whose responsibilities require knowledge of Latin America’s regulatory environment.
• Administrative staff responsible for ensuring compliance with regulatory filings and overall regulatory compliance requirements will also find this training highly relevant.
• Any sales or general management employee requiring an understanding of how regulations and compliance issues impact the organization will also benefit.

Instructor Profile:
Robert J. Russell, For the past 9 years, Bob has been President of RJR Consulting, Inc. The company assists the pharmaceutical, medical device and biotech industries in understanding and complying with International Regulations affecting compliance, new product development, manufacturing and quality assurance. RJR has offices in Columbus, OH, Washington, DC, Brussels, Belgium with exclusive affiliates across Asia and Latin America. Bob has 28 years of past industry experience as a CMC specialist, R&D Director and Global Director of Regulatory Affairs for Merion Merrill Dow pharmaceuticals and Cordis-Dow medical devices. He has a BS / MS degree in Chemistry.

Follow us :